Operating Lease, Right-of-Use Asset of MBX Biosciences, Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: MBX Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
MBX Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $520,000, a 254% increase year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

MBX Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$520,000	+$373,000	+254%	30 Sep 2025	10-Q	06 Nov 2025	2025	Q3
Q2 2025	$551,000			30 Jun 2025	10-Q	07 Aug 2025	2025	Q2
Q1 2025	$91,000			31 Mar 2025	10-Q	12 May 2025	2025	Q1
Q4 2024	$119,000	-$107,000	-47%	31 Dec 2024	10-Q	06 Nov 2025	2025	Q3
Q3 2024	$147,000			30 Sep 2024	10-Q	07 Nov 2024	2024	Q3
Q4 2023	$226,000			31 Dec 2023	10-K	17 Mar 2025	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.